FATE : Fate Therapeutics stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2024-12-04 |
|---|---|---|---|---|
| 2025 | $1.84 | $1.14 | $2.54 | -28.23% |
| 2026 | $0.98 | $0.64 | $1.15 | -61.63% |
| 2027 | $0.44 | $0.36 | $0.58 | -82.97% |
| 2028 | $0.32 | $0.3 | $0.35 | -87.4% |
| 2029 | $0.44 | $0.37 | $0.48 | -82.67% |
| 2030 | $0.65 | $0.48 | $0.99 | -74.61% |
| 2031 | $1.69 | $1.09 | $2.26 | -33.86% |
| 2032 | $4.15 | $2.4 | $5.77 | 62.08% |
| 2033 | $5.86 | $5.54 | $6.12 | 129.08% |
| 2034 | $5.78 | $5.58 | $6.11 | 125.65% |
The 2 Wall Street analysts offering Fate Therapeutics stock forecast in the last 6 months have average price target of
$5.5 with a high forecast of $6.0 and a low forecast of $5.0.
The average Fate Therapeutics stock forecast represents a 114.84%
increase from the last price of $2.55999994277954.
For Fate Therapeutics stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Fate Therapeutics stock
forecast of $1.84, a high forecast of $2.54, and a low forecast of $1.14.
The average Fate Therapeutics stock forecast 2025 represents a -28.23%
decrease from the last price of $2.55999994277954.
For Fate Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Fate Therapeutics stock
forecast of $0.98, a high forecast of $1.15, and a low forecast of $0.64.
The average Fate Therapeutics stock forecast 2026 represents a -61.63%
decrease from the last price of $2.55999994277954.
For Fate Therapeutics stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Fate Therapeutics stock
forecast of $0.32, a high forecast of $0.35, and a low forecast of $0.3.
The average Fate Therapeutics stock forecast 2028 represents a -87.4%
decrease from the last price of $2.55999994277954.
For Fate Therapeutics stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Fate Therapeutics stock
forecast of $0.65, a high forecast of $0.99, and a low forecast of $0.48.
The average Fate Therapeutics stock forecast 2030 represents a -74.61%
decrease from the last price of $2.55999994277954.
For Fate Therapeutics stock forecast 2031, 12 predictions are offered for each month of 2031 with average Fate Therapeutics stock
forecast of $1.69, a high forecast of $2.26, and a low forecast of $1.09.
The average Fate Therapeutics stock forecast 2031 represents a -33.86%
decrease from the last price of $2.55999994277954.
Please, see more forecasts below.
FATE : Fate Therapeutics stock forecast by Wall Street Analysts
The average Fate Therapeutics stock forecast from last 6 month is $5.5, and this show a 22.22% increase in average from the prior price target of the each prediction. Also, this average forecast of $5.5 represents a -17.79% decrease from the past average forecast of $6.69, 6 months ago from 13 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-11-19 | Needham | Hold | ||
| 2024-11-13 | Needham | Hold | ||
| 2024-08-22 | HC Wainwright & Co. | $5.00 | $5.00 | Neutral |
| 2024-08-14 | Needham | Hold | ||
| 2024-06-17 | Piper Sandler | $4.00 | $6 | Overweight |
| 2024-05-16 | HC Wainwright & Co. | $7.00 | $5.0000 | Neutral |
| 2024-05-10 | Canaccord Genuity | $11.0000 | $9.0000 | Buy |
| 2024-05-10 | Piper Sandler | $7.0000 | $4 | Neutral |
| 2024-05-10 | Wedbush | $7.00 | $5.0000 | Neutral |
| 2024-05-10 | BMO Capital | $7.00 | $6 | Market Perform |
| 2024-05-06 | Wedbush | $7.0000 | Neutral | |
| 2024-04-23 | Wedbush | $7.0000 | Neutral | |
| 2024-04-11 | Needham | Hold | ||
| 2024-03-28 | B of A Securities | $2.0000 | $6.0000 | Underperform |
| 2024-03-19 | HC Wainwright & Co. | $7.0000 | Neutral | |
| 2024-02-27 | Morgan Stanley | $3.00 | $7 | Equal-Weight |
| 2024-02-27 | Oppenheimer | Perform | ||
| 2024-02-27 | Wedbush | $3.00 | $7.0000 | Neutral |
| 2024-02-27 | Barclays | $6.00 | $10.0000 | Overweight |
| 2024-02-27 | BMO Capital | $6.00 | $7 | Market Perform |
Fate Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2024-12-06 | $2.64 | 3.01% |
| 2024-12-09 | $2.53 | -3.87% |
| 2024-12-10 | $2.36 | -6.99% |
| 2024-12-11 | $2.28 | -3.24% |
| 2024-12-12 | $2.18 | -4.65% |
FATE : Long term Fate Therapeutics stock forecast for 2024 - 2025 - 2030
Forecast for 2025 Jan. is $2.54 , for 2025 Dec. is $1.14 , for 2028 Dec. is $.35 , for 2029 Dec. is $.48 , for 2033 Dec. is $5.54 , and for 2034 Dec. is $6.11.
FATE : Fate Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $2.54 | -0.96% |
| 2025 Feb. | $2.49 | -1.74% |
| 2025 Mar. | $2.42 | -3.05% |
| 2025 Apr. | $2.30 | -4.77% |
| 2025 May. | $2.13 | -7.24% |
| 2025 Jun. | $1.93 | -9.67% |
| 2025 Jul. | $1.71 | -11.29% |
| 2025 Aug. | $1.54 | -9.87% |
| 2025 Sep. | $1.40 | -9.15% |
| 2025 Oct. | $1.27 | -9.07% |
| 2025 Nov. | $1.18 | -7.13% |
| 2025 Dec. | $1.14 | -3.79% |
FATE : Fate Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $1.13 | -0.62% |
| 2026 Feb. | $1.14 | 0.59% |
| 2026 Mar. | $1.15 | 0.71% |
| 2026 Apr. | $1.15 | 0.01% |
| 2026 May. | $1.13 | -1.26% |
| 2026 Jun. | $1.09 | -3.75% |
| 2026 Jul. | $1.03 | -5.81% |
| 2026 Aug. | $.95 | -7.02% |
| 2026 Sep. | $.88 | -8.21% |
| 2026 Oct. | $.79 | -9.24% |
| 2026 Nov. | $.72 | -9.86% |
| 2026 Dec. | $.64 | -9.96% |
FATE : Fate Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $.58 | -9.67% |
| 2027 Feb. | $.53 | -8.76% |
| 2027 Mar. | $.49 | -7.75% |
| 2027 Apr. | $.46 | -6.57% |
| 2027 May. | $.44 | -4.99% |
| 2027 Jun. | $.42 | -3.41% |
| 2027 Jul. | $.41 | -2.74% |
| 2027 Aug. | $.40 | -1.89% |
| 2027 Sep. | $.39 | -2.06% |
| 2027 Oct. | $.38 | -2.47% |
| 2027 Nov. | $.37 | -2.96% |
| 2027 Dec. | $.36 | -3.33% |
FATE : Fate Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $.35 | -3.54% |
| 2028 Feb. | $.33 | -3.65% |
| 2028 Mar. | $.32 | -3.35% |
| 2028 Apr. | $.31 | -2.69% |
| 2028 May. | $.31 | -1.93% |
| 2028 Jun. | $.30 | -1.05% |
| 2028 Jul. | $.30 | 0.06% |
| 2028 Aug. | $.31 | 1.10% |
| 2028 Sep. | $.31 | 2.12% |
| 2028 Oct. | $.32 | 3.05% |
| 2028 Nov. | $.34 | 3.84% |
| 2028 Dec. | $.35 | 4.41% |
FATE : Fate Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $.37 | 4.76% |
| 2029 Feb. | $.39 | 4.88% |
| 2029 Mar. | $.40 | 4.77% |
| 2029 Apr. | $.42 | 4.45% |
| 2029 May. | $.44 | 3.93% |
| 2029 Jun. | $.45 | 3.25% |
| 2029 Jul. | $.47 | 2.45% |
| 2029 Aug. | $.47 | 1.63% |
| 2029 Sep. | $.48 | 0.87% |
| 2029 Oct. | $.48 | 0.29% |
| 2029 Nov. | $.48 | -0.04% |
| 2029 Dec. | $.48 | -0.05% |
FATE : Fate Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $.48 | 0.28% |
| 2030 Feb. | $.48 | 0.92% |
| 2030 Mar. | $.49 | 1.89% |
| 2030 Apr. | $.51 | 3.19% |
| 2030 May. | $.53 | 4.83% |
| 2030 Jun. | $.57 | 6.66% |
| 2030 Jul. | $.62 | 8.34% |
| 2030 Aug. | $.67 | 9.48% |
| 2030 Sep. | $.74 | 9.97% |
| 2030 Oct. | $.82 | 10.05% |
| 2030 Nov. | $.90 | 10.10% |
| 2030 Dec. | $.99 | 10.31% |
FATE : Fate Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $1.09 | 10.51% |
| 2031 Feb. | $1.21 | 10.40% |
| 2031 Mar. | $1.33 | 9.85% |
| 2031 Apr. | $1.45 | 8.98% |
| 2031 May. | $1.56 | 7.90% |
| 2031 Jun. | $1.67 | 6.79% |
| 2031 Jul. | $1.76 | 5.86% |
| 2031 Aug. | $1.86 | 5.21% |
| 2031 Sep. | $1.95 | 4.86% |
| 2031 Oct. | $2.04 | 4.82% |
| 2031 Nov. | $2.14 | 5.02% |
| 2031 Dec. | $2.26 | 5.45% |
FATE : Fate Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $2.40 | 6.25% |
| 2032 Feb. | $2.59 | 7.98% |
| 2032 Mar. | $2.88 | 11.17% |
| 2032 Apr. | $3.28 | 13.83% |
| 2032 May. | $3.71 | 13.18% |
| 2032 Jun. | $4.11 | 10.75% |
| 2032 Jul. | $4.46 | 8.50% |
| 2032 Aug. | $4.77 | 6.85% |
| 2032 Sep. | $5.04 | 5.64% |
| 2032 Oct. | $5.27 | 4.58% |
| 2032 Nov. | $5.50 | 4.40% |
| 2032 Dec. | $5.77 | 5.00% |
FATE : Fate Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $5.84 | 1.16% |
| 2033 Feb. | $5.87 | 0.41% |
| 2033 Mar. | $5.92 | 0.86% |
| 2033 Apr. | $6.00 | 1.36% |
| 2033 May. | $6.08 | 1.40% |
| 2033 Jun. | $6.12 | 0.71% |
| 2033 Jul. | $6.09 | -0.56% |
| 2033 Aug. | $5.96 | -2.13% |
| 2033 Sep. | $5.78 | -3.01% |
| 2033 Oct. | $5.63 | -2.58% |
| 2033 Nov. | $5.55 | -1.38% |
| 2033 Dec. | $5.54 | -0.17% |
FATE : Fate Therapeutics stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $5.58 | 0.68% |
| 2034 Feb. | $5.64 | 1.04% |
| 2034 Mar. | $5.67 | 0.62% |
| 2034 Apr. | $5.68 | 0.04% |
| 2034 May. | $5.69 | 0.24% |
| 2034 Jun. | $5.71 | 0.37% |
| 2034 Jul. | $5.74 | 0.45% |
| 2034 Aug. | $5.77 | 0.57% |
| 2034 Sep. | $5.82 | 0.86% |
| 2034 Oct. | $5.90 | 1.44% |
| 2034 Nov. | $6.01 | 1.82% |
| 2034 Dec. | $6.11 | 1.68% |
Frequently Asked Questions about Fate Therapeutics stock forecast
Is Fate Therapeutics a good long term stock?
From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2025 Jan. is $2.53546369562055 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2025 Dec. is $1.13757932444644 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2028 Dec. is $0.351774976644199 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2029 Dec. is $0.477690763416925 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock can be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2033 Dec. is $5.54312487585009 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock can be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2034 Dec. is $6.11102058273941
Is Fate Therapeutics stock overvalued?
Fate Therapeutics (FATE) stock is expected to go DOWN . Therefore, AIPickup would say that Fate Therapeutics (FATE) stock is overvalued.
Will Fate Therapeutics stock price go up?
No. The Fate Therapeutics stock price forecast for 2025 Dec. is $1.13757932444644
Is Fate Therapeutics stock a good buy now?
Since closing price on 2024-12-04 is $2.55999994277954 and forecast for 2025 Dec. is $1.14, Fate Therapeutics stock is not a good 1 year investment.
14 Days Historical Data for Fate Therapeutics stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| FATE stock price for 2024-11-14 | $2.08 | $2.18 | $2.05 | $2.22 |
| FATE stock price for 2024-11-15 | $2.02 | $2.11 | $1.96 | $2.12 |
| FATE stock price for 2024-11-18 | $2.27 | $2.26 | $2.23 | $3.50 |
| FATE stock price for 2024-11-19 | $2.18 | $2.20 | $2.03 | $2.26 |
| FATE stock price for 2024-11-20 | $2.22 | $2.16 | $2.03 | $2.35 |
| FATE stock price for 2024-11-21 | $2.07 | $2.23 | $2.01 | $2.28 |
| FATE stock price for 2024-11-22 | $2.29 | $2.10 | $2.07 | $2.36 |
| FATE stock price for 2024-11-25 | $2.42 | $2.38 | $2.35 | $2.53 |
| FATE stock price for 2024-11-26 | $2.68 | $2.72 | $2.42 | $3.32 |
| FATE stock price for 2024-11-27 | $3.17 | $2.68 | $2.68 | $3.27 |
| FATE stock price for 2024-11-29 | $3.17 | $3.14 | $3.07 | $3.43 |
| FATE stock price for 2024-12-02 | $2.96 | $3.14 | $2.82 | $3.39 |
| FATE stock price for 2024-12-03 | $2.63 | $2.94 | $2.58 | $2.98 |
| FATE stock price for 2024-12-04 | $2.56 | $2.66 | $2.53 | $2.75 |